血小板活化和弗林蛋白酶的血浆水平与冠心病和 COVID-19 患者的预后相关。
Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19.
机构信息
Department of Cardiology and Angiology (C.L., A.-K.R., S.G., Á.P.-U., P.J., A.A., T.H., K.-P.K., T.C., D.R., M.P.G., K.A.L.M.), University Hospital Tuebingen, Eberhard Karls University Tuebingen, Germany.
Department of Hematology, Oncology, Clinical Immunology and Rheumatology (M.G., S.P., S.E.A.), University Hospital Tuebingen, Eberhard Karls University Tuebingen, Germany.
出版信息
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):2080-2096. doi: 10.1161/ATVBAHA.120.315698. Epub 2021 Apr 29.
Abstract
[Figure: see text].
摘要
[图：见正文]。
相似文献
1
Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19.血小板活化和弗林蛋白酶的血浆水平与冠心病和 COVID-19 患者的预后相关。
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):2080-2096. doi: 10.1161/ATVBAHA.120.315698. Epub 2021 Apr 29.
2
Artifactual elevation of plasma sCD40L by residual platelets in patients with coronary artery disease.冠心病患者中残余血小板导致血浆可溶性CD40配体假性升高。
Int J Cardiol. 2013 Sep 30;168(2):1648-50. doi: 10.1016/j.ijcard.2013.03.019. Epub 2013 Apr 8.
3
Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response.新型检测方法显示，冠心病患者的促凝血小板反应增强。
J Thromb Haemost. 2018 Jun;16(6):1198-1210. doi: 10.1111/jth.14008. Epub 2018 May 8.
4
P-selectin (CD62P) and soluble TREM-like transcript-1 (sTLT-1) are associated with coronary artery disease: a case control study.P 选择素（CD62P）和可溶性髓样细胞触发受体样转录物-1（sTLT-1）与冠状动脉疾病相关：一项病例对照研究。
BMC Cardiovasc Disord. 2020 Aug 24;20(1):387. doi: 10.1186/s12872-020-01663-2.
5
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.在首次诊断出冠状动脉疾病之前，HIV阳性个体中血小板衍生的可溶性糖蛋白VI水平降低。
Platelets. 2017 May;28(3):301-304. doi: 10.1080/09537104.2016.1237627. Epub 2016 Nov 16.
6
Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid.同型半胱氨酸水平对接受乙酰水杨酸治疗的冠状动脉疾病患者血小板反应性的影响。
J Cardiovasc Pharmacol. 2015 Jul;66(1):35-40. doi: 10.1097/FJC.0000000000000240.
7
Circulating furin, IL-6, and presepsin levels and disease severity in SARS-CoV-2-infected patients.循环中弗林蛋白酶、白细胞介素 6 和降钙素原水平与 SARS-CoV-2 感染患者的疾病严重程度。
Sci Prog. 2021 Jun;104(2_suppl):368504211026119. doi: 10.1177/00368504211026119.
8
Correlations between platelet-derived microvesicles and thrombin generation in patients with coronary artery disease.冠状动脉疾病患者血小板衍生微泡与凝血酶生成之间的相关性。
Platelets. 2008 Sep;19(6):476-7. doi: 10.1080/09537100802210337.
9
Enhanced P-selectin expression on platelet-a marker of platelet activation, in young patients with angiographically proven coronary artery disease.经血管造影证实患有冠状动脉疾病的年轻患者血小板上增强的P-选择素表达——血小板活化的标志物
Mol Cell Biochem. 2016 Aug;419(1-2):125-33. doi: 10.1007/s11010-016-2756-4. Epub 2016 Jul 12.
10
The influence of low-grade inflammation on platelets in patients with stable coronary artery disease.低度炎症对稳定型冠状动脉疾病患者血小板的影响。
Thromb Haemost. 2015 Aug 31;114(3):519-29. doi: 10.1160/TH14-12-1007. Epub 2015 Jun 11.
引用本文的文献
1
Complex Pattern of Platelet Activation/Reactivity After SARS-CoV-2 Infection.新型冠状病毒感染后血小板激活/反应性的复杂模式
Int J Mol Sci. 2024 Dec 24;26(1):49. doi: 10.3390/ijms26010049.
2
Hemin-induced platelet activation is regulated by the ACKR3 chemokine surface receptor and has implications for passivation of vulnerable atherosclerotic plaques.血红素诱导的血小板活化受ACKR3趋化因子表面受体调控，对易损动脉粥样硬化斑块的钝化具有重要意义。
FEBS J. 2024 Dec;291(24):5420-5434. doi: 10.1111/febs.17294. Epub 2024 Oct 10.
3
The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk.丝氨酸蛋白酶 furin 在心血管疾病风险中的作用及其治疗潜力。
Int J Mol Sci. 2024 Aug 26;25(17):9237. doi: 10.3390/ijms25179237.
4
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中宿主硫酸乙酰肝素蛋白聚糖的治疗性开发。
Front Med (Lausanne). 2024 Mar 27;11:1364657. doi: 10.3389/fmed.2024.1364657. eCollection 2024.
5
Functional Roles of Furin in Cardio-Cerebrovascular Diseases.弗林蛋白酶在心血管疾病中的功能作用
ACS Pharmacol Transl Sci. 2024 Feb 7;7(3):570-585. doi: 10.1021/acsptsci.3c00325. eCollection 2024 Mar 8.
6
A systematic review and meta-analysis on the prevalence and impact of coronary artery disease in hospitalized COVID-19 patients.关于住院COVID-19患者冠状动脉疾病患病率及影响的系统评价和荟萃分析。
Heliyon. 2023 Aug 25;9(9):e19493. doi: 10.1016/j.heliyon.2023.e19493. eCollection 2023 Sep.
7
SARS-CoV-2 Spike Protein and Neutralizing Anti-Spike Protein Antibodies Modulate Blood Platelet Function.SARS-CoV-2 刺突蛋白和中和抗刺突蛋白抗体调节血小板功能。
Int J Mol Sci. 2023 Mar 10;24(6):5312. doi: 10.3390/ijms24065312.
8
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer's and coronary disease pathways.新型冠状病毒感染与严重程度的血浆蛋白质组学揭示了对阿尔茨海默病和冠心病通路的影响。
iScience. 2023 Apr 21;26(4):106408. doi: 10.1016/j.isci.2023.106408. Epub 2023 Mar 14.
9
Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation.COVID-19 期间脑卒中患者的抗磷脂抗体：在导致血小板激活的信号通路中的作用。
Front Immunol. 2023 Mar 2;14:1129201. doi: 10.3389/fimmu.2023.1129201. eCollection 2023.
10
Dysregulated haemostasis in thrombo-inflammatory disease.血栓炎症性疾病中的血液失调。
Clin Sci (Lond). 2022 Dec 22;136(24):1809-1829. doi: 10.1042/CS20220208.
本文引用的文献
1
Antibody-induced procoagulant platelets in severe COVID-19 infection.严重 COVID-19 感染中的抗体诱导的促凝血小板。
Blood. 2021 Feb 25;137(8):1061-1071. doi: 10.1182/blood.2020008762.
2
Protease-activated receptor 1 as a potential therapeutic target for COVID-19.蛋白酶激活受体 1 作为 COVID-19 的潜在治疗靶点。
Exp Biol Med (Maywood). 2021 Mar;246(6):688-694. doi: 10.1177/1535370220978372. Epub 2020 Dec 10.
3
The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes.骨桥蛋白和弗林蛋白酶在合并糖尿病的 COVID-19 患者疾病转归恶化中的潜在作用。
Cells. 2020 Nov 23;9(11):2528. doi: 10.3390/cells9112528.
4
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.血小板病和血管内皮病：COVID-19 血栓炎症的重要促成因素。
Nat Rev Cardiol. 2021 Mar;18(3):194-209. doi: 10.1038/s41569-020-00469-1. Epub 2020 Nov 19.
5
Numbers and phenotype of non-classical CD14dimCD16+ monocytes are predictors of adverse clinical outcome in patients with coronary artery disease and severe SARS-CoV-2 infection.非经典 CD14dimCD16+ 单核细胞的数量和表型是冠心病和严重 SARS-CoV-2 感染患者不良临床结局的预测指标。
Cardiovasc Res. 2021 Jan 1;117(1):224-239. doi: 10.1093/cvr/cvaa328.
6
The Immune Nature of Platelets Revisited.血小板的免疫本质再探。
Transfus Med Rev. 2020 Oct;34(4):209-220. doi: 10.1016/j.tmrv.2020.09.005. Epub 2020 Sep 19.
7
Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis.体重指数（BMI）增加和肥胖对 COVID-19 成年患者结局的影响：系统评价和荟萃分析。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1897-1904. doi: 10.1016/j.dsx.2020.09.029. Epub 2020 Sep 28.
8
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects.弗林蛋白酶抑制剂可阻断 SARS-CoV-2 刺突蛋白裂解，抑制病毒产生和细胞病变效应。
Cell Rep. 2020 Oct 13;33(2):108254. doi: 10.1016/j.celrep.2020.108254. Epub 2020 Sep 23.
9
Obesity in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者中的肥胖症：系统评价和荟萃分析。
Metabolism. 2020 Dec;113:154378. doi: 10.1016/j.metabol.2020.154378. Epub 2020 Sep 28.
10
Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19.有症状的COVID-19患者血栓形成事件的发生率和结局
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):545-547. doi: 10.1161/ATVBAHA.120.315304. Epub 2020 Sep 29.
Zotero 插件